NDC 50474-983-86
RYSTIGGO 140 mg/mL
ROZANOLIXIZUMAB · INJECTION, SOLUTION
RYSTIGGO is a injection, solution containing rozanolixizumab at a strength of 140 mg/mL. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- RYSTIGGO
- Generic Name
- ROZANOLIXIZUMAB
- NDC Code (Package)
50474-983-86- NDC Code (Product)
50474-983- Manufacturer
- UCB, Inc.
- Strength
- 140 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761286
- Drug Class
- Neonatal Fc Receptor Blocker [EPC]
- Marketing Start
- 06/14/2024
Recall History
No Recall HistoryView Full Drug Page
RYSTIGGO — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.